Primary Record
Rilzabrutinib
- In stock
- 6,403 g
- Purity
- 99.3 %
- CAS
- 1575596-29-0
Compound Identifiers & Properties
- CAS
- 1575596-29-0
- PubChem CID
- 73388818
- SMILES
- CC(C)(/C=C(\C#N)/C(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=C(C=C(C=C4)OC5=CC=CC=C5)F)N)N6CCN(CC6)C7COC7
- Canonical SMILES
- CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1
Names & Synonyms
- Rilzabrutinib
- PRN1008
- Wayrilz
- Rilzabrutinib [INN]
- Rilzabrutinib [USAN]
- Wayrilz (TN)
- Rilzabrutinib, (E)-
- 1575596-29-0
- PRN-1008
- RefChem:883642
- NWN58M4F5T
- UNII-NWN58M4F5T
- Rilzabrutinib [USAN:INN]
- 5G1WE425BI
- Rilzabrutinib (PRN1008)
- UNII-5G1WE425BI
- GTPL9993
- orb1309216
- CHEMBL3702854
- Rilzabrutinib (JAN/USAN/INN)
- SCHEMBL29368877
- SCHEMBL29564512
- C36H40FN9O3
- Rilzabrutinib, (.alpha.e,3s)-
- BDBM143212
- PRN1008, (E)-
- EX-A4524
- PRN 1008
- PRN-1008, (E)-
- BDBM50557485
- EBC-64029
- EBC-84050
- Example 31 [WO2014039899]
- NSC812901
- PRN 1008?
- WHO 10966
- 1575591-66-0
- AKOS040735411
- NSC-812901
- Example 31 (WO2014039899)
- AC-36557
- DA-77069
- FP167893
- MS-31034
- (E)-2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
- HY-112166
- HY-151232
- CS-0043590
- J3.802.355A
- D11873
- D87222
- EN300-1608336
- EN300-7487650
- US8940744, 31
- (R)-2-(3-(4-Amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile
- (R,E)-2-(3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile
- A1001423
- Q50825085
- (2E)-2-[(E)-(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
- (2E)-2-{(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl}-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
- (E/Z)-(R)-2-(3-(4-Amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile
- 1-Piperidinepropanenitrile, 3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)-alpha-(2-methyl-2-(4-(3-oxetanyl)-1-piperazinyl)propylidene)-beta-oxo-, (alphaE/Z,3R)-
- 2-((3R)-2-(4-Amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)piperdine-1-carbonyl)-4-methyl-4(4-(oxetan-3-yl)piperazin-1-yl-(E)-pent-2-enenitrile
- (|AE,3R)-3-[4-Amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-|A-[2-methyl-2-[4-(3-oxetanyl)-1-piperazinyl]propylidene]-|A-oxo-1-piperidinepropanenitrile
- (2E)-2-[(E)-(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
- (E)-2-((3R)-3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile
- (E)-2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
- 1-PIPERIDINEPROPANENITRILE, 3-(4-AMINO-3-(2-FLUORO-4-PHENOXYPHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)-.ALPHA.-(2-METHYL-2-(4-(3-OXETANYL)-1-PIPERAZINYL)PROPYLIDENE)-.BETA.-OXO-, (.ALPHA.E/Z,3R)-
- 1-Piperidinepropanenitrile, 3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1Hpyrazolo(3,4-d)pyrimidin-1-yl)-alpha-(2-methyl-2-(4-(3-oxetanyl)-1-piperazinyl)propylidene)-beta-oxo-, (3R)-
- 2-[(3R)-3-[3-(2-fluoro-4-phenoxyphenyl)-4-imino-1H,2H,4H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
- 2416219-30-0
- N/A
- R1L